Invention Grant
US08552031B2 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
失效
3-亚乙基肼基取代的杂环化合物作为血小板生成素受体激活剂
- Patent Title: 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
- Patent Title (中): 3-亚乙基肼基取代的杂环化合物作为血小板生成素受体激活剂
-
Application No.: US11721252Application Date: 2005-12-07
-
Publication No.: US08552031B2Publication Date: 2013-10-08
- Inventor: Katsuaki Miyaji , Yukihiro Shigeta , Satoshi Nakano , Shunuske Iwamoto , Yutaka Hirokawa , Hirofumi Ota , Kazufumi Yanagihara , Shingo Owada , Norihisa Ishiwata
- Applicant: Katsuaki Miyaji , Yukihiro Shigeta , Satoshi Nakano , Shunuske Iwamoto , Yutaka Hirokawa , Hirofumi Ota , Kazufumi Yanagihara , Shingo Owada , Norihisa Ishiwata
- Applicant Address: JP Tokyo
- Assignee: Nissan Chemical Industries, Ltd.
- Current Assignee: Nissan Chemical Industries, Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2004-355195 20041208; JP2005-330891 20051115
- International Application: PCT/JP2005/022907 WO 20051207
- International Announcement: WO2006/062240 WO 20060615
- Main IPC: A01N43/40
- IPC: A01N43/40 ; A61K31/445 ; C07D211/68 ; C07D211/80 ; C07D213/02 ; C07D401/00 ; C07D409/00
Abstract:
A compound represented by the formula (1): wherein A, B, R1, L1, R2, L2, L3, Y, L4, R3 and X are the same as defined in the description, a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
Public/Granted literature
- US20090281317A1 3-ETHYLIDENEHYDRAZINO SUBSTITUTED HETEROCYCLIC COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS Public/Granted day:2009-11-12
Information query
IPC分类:
